Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.

Medical Devices

Ypsomed

Simon Michel

Samuel Künzli

Nicolas Meyer

Ulrike Bauer

Sébastien Delarive

Michael Zaugg

Frank Mengis

The Software Development Team at Ypsomed collaborates to design, develop, and maintain software solutions essential for the company's cutting-edge medical devices and injection systems. This team ensures robust software infrastructure, from embedded systems and SAP applications to cloud-based services and network security, enhancing product functionality and reliability, particularly in the areas of diabetes care and injection systems. Their expertise spans across development, testing, and deployment, ensuring seamless integration and performance of Ypsomed's technological offerings.

Software Development Team

Business Development

Engineering and IT

Software Development Team

About

Team members

Other teams at Ypsomed

Business Development

Engineering and IT